selected publications
-
HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.
Cancer cell.
2018
Academic Article
GET IT
Times cited: 69 -
Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation.
2018
GET IT
Times cited: 1 -
LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML.
Blood.
2018
Academic Article
GET IT
Times cited: 69 -
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches.
Molecular cell.
2015
Review
GET IT
Times cited: 39